Enhanced levels of biochemical markers for cobalamin deficiency in totally gastrectomized rats: uncoupling of the enhancement from the severity of spongy vacuolation in spinal cord.
The totally gastrectomized (TGX) rat is a new experimental model for studying the pathogenesis of cobalamin (Cbl)-deficient myelopathy, i.e., subacute combined degeneration, total gastrectomy (TG) serving as a surgical paradigm of human pernicious anemia. We determined the serum levels of some biochemical indicators of Cbl deficiency in TGX rats at 2 to 10 months after TG. Methylmalonic acid (MMA) rose within 2 months and progressively increased thereafter until the end of the investigation period. 2-Methylcitric acid (MCA) rose significantly by 6 months and showed a further increment 4 months later. Homocysteine was only clearly elevated much later than the serum MMA, i.e., 10 months after the operation. The concentrations of MMA, MCA, and cystathionine were increased in kidney, liver, and spinal cord (SC) of TGX rats at 10 months. Chronic treatment of TGX rats with Cbl greatly decreased the serum levels of all the metabolic indicators of Cbl deficiency. Chronic peroral administration of the antibiotic lincomycin to TGX rats in an attempt to suppress the enteric flora markedly decreased serum MMA levels. Only Cbl, however, given either for the first 2 months after TG or for the third and fourth postoperative months (i.e., after SC abnormalities had already appeared) significantly decreased the severity of spongy vacuolation in SC white matter, although not completely preventing or repairing the neuropathological damage. Therefore, neither the early impairment in TGX rats of the Cbl-dependent methylmalonyl-coenzyme A mutase reaction nor the more delayed impairment of the Cbl-dependent methionine synthase step, as reflected by changes in serum metabolite levels, seems to be causally related to the TG-induced spongy vacuolation in SC white matter.
Scalabrino
G
G
Institute of General Pathology, University of Milan, Italy.
Buccellato
F R
FR
Tredici
G
G
Morabito
A
A
Lorenzini
E C
EC
Allen
R H
RH
Lindenbaum
J
J
D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase / Q000378:metabolism; D000752:Anemia, Pernicious; D000818:Animals; D001421:Bacteria, Anaerobic / Q000187:drug effects; D002951:Citrates / Q000097:blood*; D003540:Cystathionine / Q000097:blood*; D004195:Disease Models, Animal; D004917:Erythromycin / Q000494:pharmacology; D005743:Gastrectomy / Q000009:adverse effects*; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D007422:Intestines / Q000382:microbiology; D008034:Lincomycin / Q000008:administration & dosage / Q000494:pharmacology; D008297:Male; D008764:Methylmalonic Acid / Q000097:blood*; D008765:Methylmalonyl-CoA Mutase / Q000378:metabolism; D011178:Postgastrectomy Syndromes / Q000097:blood*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013116:Spinal Cord / Q000473:pathology*; D013118:Spinal Cord Diseases; D014617:Vacuoles / Q000473:pathology; D014805:Vitamin B 12 / Q000627:therapeutic use; D014806:Vitamin B 12 Deficiency / Q000097:blood / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology
D002951:Citrates; D006710:Homocysteine; D003540:Cystathionine; C031605:2-methylcitric acid; D004917:Erythromycin; D008764:Methylmalonic Acid; D008034:Lincomycin; D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; D008765:Methylmalonyl-CoA Mutase; D014805:Vitamin B 12